China Pharma Holdings (CPHI) Cash from Operations Growth (3y) (2013 - 2026)
China Pharma Holdings (CPHI) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 34.90% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -9.94% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 7.32% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 46.81% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 27.85% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -98.15% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 4.87% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 102.19% |
| 10 | China Pharma Holdings | 18.56 Mn | 18.39 Mn | 285,487.00 | 66.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.48% |
| Dec 31, 2025 | -36.18% |
| Sep 30, 2025 | -45.52% |
| Jun 30, 2025 | 42.92% |
| Mar 31, 2025 | 56.24% |
| Dec 31, 2024 | 51.95% |
| Sep 30, 2024 | 52.95% |
| Jun 30, 2024 | -28.21% |
| Mar 31, 2024 | -28.32% |
| Dec 31, 2023 | -27.38% |
| Sep 30, 2023 | 86.52% |
| Jun 30, 2023 | -63.46% |
| Mar 31, 2023 | -81.85% |
| Dec 31, 2022 | 205.28% |
| Sep 30, 2022 | -23.01% |
| Jun 30, 2022 | -42.00% |
| Mar 31, 2022 | -54.93% |
| Dec 31, 2021 | -30.58% |
| Sep 30, 2021 | -35.91% |
| Jun 30, 2021 | 54.57% |